+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma

Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma

Current Eye Research 11(3): 279-283

There is substantial indirect evidence which suggests that Chlamydia trachomatis can generate inapparent, persistent infections in human. To confirm this directly, we examined ocular chlamydial infection in both the cynomolgus monkey model of trachoma and in patient samples from a trachoma-endemic area. In monkeys, ocular infection was studied over time using direct immunofluorescence cytology (DFA) and a molecular hybridization screening system which targets chlamydial ribosomal RNA. In eleven animals infected once with B serovar, DFA and probe screening of parallel conjunctival swabs gave congruent results through day 42 post-infection. Thereafter, DFA showed clearing of chlamydia and was negative by day 70, as in previous studies. In contrast, hybridization analysis indicated a continuing presence of chlamydial RNA in all samples from all animals through the end of the experiment at day 84 post-infection. Similarly, analysis of swabs from trachoma patients showed that a number of DFA-negative samples gave clear positive signal for chlamydial RNA. Taken together these data indicate that ocular chlamydial infection persists for longer periods than previously thought, judging solely on the basis of DFA, and they support the idea that inapparent ocular chlamydial infection occurs in vivo.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040399937

Download citation: RISBibTeXText

PMID: 1375138

DOI: 10.3109/02713689209001780

Related references

Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?. Plos Medicine 3(8): E266, 2006

Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau. Plos Neglected Tropical Diseases 8(6): E2900, 2014

Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme. Tanzania Journal of Health Research 11(3): 103-110, 2009

Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger. British Journal of Ophthalmology 91(1): 13-17, 2007

The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection. Expert Review of Anti-infective Therapy 1(2): 209-216, 2003

The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection. Expert Review of Anti-Infective Therapy 1(2): 209-216, 2003

Characterization of local cytokine response to Chlamydia trachomatis ocular-infection in trachoma. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 179, 1995

Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification. Investigative Ophthalmology and Visual Science 50(1): 90-94, 2009

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment. Plos Neglected Tropical Diseases 10(10): E0005080, 2016

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?. Plos Neglected Tropical Diseases 3(12): E573, 2009

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji. Plos Neglected Tropical Diseases 10(7): E0004798, 2016

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Investigative Ophthalmology & Visual Science 48(4): 1492-1497, 2007

Does Chlamydia trachomatis MoPn enter a microbiologically-inapparent state during experimental infection of the mouse genital tract?. Microbial Pathogenesis 22(2): 99-112, 1997

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. Plos Neglected Tropical Diseases 11(9): E0005863, 2017

Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma. Clinical Infectious Diseases 54(2): 253-256, 2012